🚀 VC round data is live in beta, check it out!
Colgate-Palmolive Valuation Multiples
Discover revenue and EBITDA valuation multiples for Colgate-Palmolive and similar public comparables like Hindustan Unilever, Reckitt, Haleon, Bayer and more.
Colgate-Palmolive Overview
About Colgate-Palmolive
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one-fifth of sales), which sells a majority of its products through veterinarians and specialty pet retailers.
Founded
1923
HQ
Employees
33.6K
Website
Sectors
Financials (LTM)
EV
$85B
Colgate-Palmolive Financials
Colgate-Palmolive reported last 12-month revenue of $21B and EBITDA of $5B.
In the same LTM period, Colgate-Palmolive generated $12B in gross profit, $5B in EBITDA, and $3B in net income.
Revenue (LTM)
Colgate-Palmolive P&L
In the most recent fiscal year, Colgate-Palmolive reported revenue of $20B and EBITDA of $5B.
Colgate-Palmolive expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $21B | XXX | $20B | XXX | XXX | XXX |
| Gross Profit | $12B | XXX | $12B | XXX | XXX | XXX |
| Gross Margin | 60% | XXX | 60% | XXX | XXX | XXX |
| EBITDA | $5B | XXX | $5B | XXX | XXX | XXX |
| EBITDA Margin | 24% | XXX | 24% | XXX | XXX | XXX |
| EBIT Margin | 21% | XXX | 21% | XXX | XXX | XXX |
| Net Profit | $3B | XXX | $3B | XXX | XXX | XXX |
| Net Margin | 15% | XXX | 15% | XXX | XXX | XXX |
| Net Debt | — | — | $7B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Colgate-Palmolive Stock Performance
Colgate-Palmolive has current market cap of $78B, and enterprise value of $85B.
Market Cap Evolution
Colgate-Palmolive's stock price is $97.30.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $85B | $78B | 0.0% | XXX | XXX | XXX | $3.74 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialColgate-Palmolive Valuation Multiples
Colgate-Palmolive trades at 4.1x EV/Revenue multiple, and 17.0x EV/EBITDA.
EV / Revenue (LTM)
Colgate-Palmolive Financial Valuation Multiples
As of March 18, 2026, Colgate-Palmolive has market cap of $78B and EV of $85B.
Equity research analysts estimate Colgate-Palmolive's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Colgate-Palmolive has a P/E ratio of 25.8x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $78B | XXX | $78B | XXX | XXX | XXX |
| EV (current) | $85B | XXX | $85B | XXX | XXX | XXX |
| EV/Revenue | 4.1x | XXX | 4.2x | XXX | XXX | XXX |
| EV/EBITDA | 17.0x | XXX | 17.2x | XXX | XXX | XXX |
| EV/EBIT | 19.5x | XXX | 19.6x | XXX | XXX | XXX |
| EV/Gross Profit | 6.9x | XXX | 7.0x | XXX | XXX | XXX |
| P/E | 25.8x | XXX | 26.0x | XXX | XXX | XXX |
| EV/FCF | 24.2x | XXX | 23.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Colgate-Palmolive Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Colgate-Palmolive Margins & Growth Rates
Colgate-Palmolive's revenue in the last 12 month grew by 4%.
Colgate-Palmolive's revenue per employee in the last FY averaged $0.6M.
Colgate-Palmolive's rule of 40 is 29% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Colgate-Palmolive's rule of X is 35% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Colgate-Palmolive Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Margin | 24% | XXX | 24% | XXX | XXX | XXX |
| EBITDA Growth | 4% | XXX | 4% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 29% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 35% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.6M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 13% | XXX | — | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 39% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Colgate-Palmolive Public Comps
See public comps and valuation multiples for other Health & Beauty and Home Care comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Hindustan Unilever | XXX | XXX | XXX | XXX | XXX | XXX |
| Reckitt | XXX | XXX | XXX | XXX | XXX | XXX |
| Haleon | XXX | XXX | XXX | XXX | XXX | XXX |
| Bayer | XXX | XXX | XXX | XXX | XXX | XXX |
| Galderma | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Colgate-Palmolive M&A Activity
Colgate-Palmolive acquired XXX companies to date.
Last acquisition by Colgate-Palmolive was on XXXXXXXX, XXXXX. Colgate-Palmolive acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Colgate-Palmolive
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialColgate-Palmolive Investment Activity
Colgate-Palmolive invested in XXX companies to date.
Colgate-Palmolive made its latest investment on XXXXXXXX, XXXXX. Colgate-Palmolive invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Colgate-Palmolive
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Colgate-Palmolive
| When was Colgate-Palmolive founded? | Colgate-Palmolive was founded in 1923. |
| Where is Colgate-Palmolive headquartered? | Colgate-Palmolive is headquartered in United States. |
| How many employees does Colgate-Palmolive have? | As of today, Colgate-Palmolive has over 33K employees. |
| Who is the CEO of Colgate-Palmolive? | Colgate-Palmolive's CEO is Noel R. Wallace. |
| Is Colgate-Palmolive publicly listed? | Yes, Colgate-Palmolive is a public company listed on NYSE. |
| What is the stock symbol of Colgate-Palmolive? | Colgate-Palmolive trades under CL ticker. |
| When did Colgate-Palmolive go public? | Colgate-Palmolive went public in 1951. |
| Who are competitors of Colgate-Palmolive? | Colgate-Palmolive main competitors are Hindustan Unilever, Reckitt, Haleon, Bayer. |
| What is the current market cap of Colgate-Palmolive? | Colgate-Palmolive's current market cap is $78B. |
| What is the current revenue of Colgate-Palmolive? | Colgate-Palmolive's last 12 months revenue is $21B. |
| What is the current revenue growth of Colgate-Palmolive? | Colgate-Palmolive revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of Colgate-Palmolive? | Current revenue multiple of Colgate-Palmolive is 4.1x. |
| Is Colgate-Palmolive profitable? | Yes, Colgate-Palmolive is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Colgate-Palmolive? | Colgate-Palmolive's last 12 months EBITDA is $5B. |
| What is Colgate-Palmolive's EBITDA margin? | Colgate-Palmolive's last 12 months EBITDA margin is 24%. |
| What is the current EV/EBITDA multiple of Colgate-Palmolive? | Current EBITDA multiple of Colgate-Palmolive is 17.0x. |
| What is the current FCF of Colgate-Palmolive? | Colgate-Palmolive's last 12 months FCF is $4B. |
| What is Colgate-Palmolive's FCF margin? | Colgate-Palmolive's last 12 months FCF margin is 17%. |
| What is the current EV/FCF multiple of Colgate-Palmolive? | Current FCF multiple of Colgate-Palmolive is 24.2x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.